To better understand the roles of the top candidate genes in response to anti-VEGF inhibition, we decided to focus on APLN and APLNR, both of which were found to be upregulated in the stroma from the resistant tumors compared to sensitive tumor stroma (Figure 3D, 3E). The gene discussed is APLNR; the disease is neoplasm.